News tagged with phase iii
Large clinical trial finds pirfenidone may help lung function in IPF patients
May 17, 2009 |
5 / 5 (1) |
0
A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis, or IPF.
Search results for phase iii
Are we cherry picking participants for studies of antidepressants?
Medicine & Health / Psychology & Psychiatry
Apr 28, 2009 |
4 / 5 (1) |
0
Findings from clinical studies used to gain Food and Drug Administration approval of common antidepressants are not applicable to most patients with depression, according to a report led by the University of Pittsburgh Graduate ...
AIDS: Vaccine shows positive results in small trial - researchers
Medicine & Health / HIV & AIDS
Oct 19, 2009 |
5 / 5 (1) |
0
An HIV vaccine tested in Tanzania has shown positive results in preliminary trials and may provide better protection than a promising Thai vaccine unveiled on September 24, Swedish researchers said Monday.
Extensive publication bias for Phase I drug trials
Medicine & Health / Medications
Feb 18, 2009 |
4.5 / 5 (2) |
0
A study published in this week's issue of the open-access journal PLoS Medicine suggests that, in comparison to other types of trials, the results of Phase I drug trials are far less likely to be published.
Sunshine pill for prostate cancer in 2009
Jan 16, 2007 |
4 / 5 (1) |
0
A tablet designed to emulate the healing power of the sun could be available for the treatment of advanced prostate cancer as early as 2009. But it remains to be seen whether the drug will be the revolution in prostate cancer ...
Prostate cancer vaccines more effective with hormone therapy
Jul 10, 2008 |
3.8 / 5 (4) |
1
Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, ...
Could therapeutic vaccines treat hard to beat breast cancers?
Jul 27, 2009 |
1 / 5 (1) |
0
A comprehensive analysis of nearly 1,600 tumor samples has found that CT-X genes are expressed in nearly half the breast cancers that lack the estrogen receptor (ER). CT-X gene products are the targets of therapeutic cancer ...
Triple drug combination is promising option to treat metastatic HER2+ breast cancer
May 15, 2009 |
5 / 5 (1) |
0
Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.
Scientists to test gammaglobulin treatment for Alzheimer's disease
Sep 24, 2009 |
4 / 5 (1) |
0
Researchers from the Memory and Cognition Center at University Hospitals Case Medical Center will begin testing an intriguing new approach to slowing down the progression of Alzheimer's Disease (AD) using Intravenous Immune ...
Study finds flaws in cancer clinical trials
Feb 01, 2007 |
5 / 5 (4) |
0
Cancer research and drug development are yielding more sophisticated candidate therapies, but investigators' methods to test them haven't kept pace, according to researchers at Memorial Sloan-Kettering Cancer Center. That ...
Vaccine shows therapeutic promise against advanced melanoma
Jun 01, 2009 |
1 / 5 (1) |
0
A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers ...
List of search results for phase iii
